Fierce Healthcare November 22, 2023
Paige Minemyer

Given the competition in the Medicare Advantage (MA) market, insurers are devising plenty of ways to stand out in the crowd, ranging from grocery benefits to enhanced dental coverage.

But one area that’s still lacking in many ways is in cancer coverage. Harlan Levine, M.D., president of health innovation and policy at City of Hope, told Fierce Healthcare in an interview at the HLTH conference last month that it’s critical for the industry to “modernize” the definition of parity around cancer.

“You never see someone going into the market and saying to a Medicare Advantage potential customer: We have the best cancer program for you,” he said.

Levine said the incentives aren’t yet aligned for health plans to really embrace...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Insurance, Interview / Q&A, Medicare Advantage, Trends
Growth in Medicare Advantage Raises Concerns
CMS proposes $21B payment increase for Medicare Advantage in 2026: 10 notes
Medicare Advantage leads to lower cancer drug costs in colorectal cancer
A Stronger Medicare Program—Now And Into The Future
Medicare Privatization Is Breaking the Bank

Share This Article